Pfizer (PFE), BioNTech (BNTX) request to amend FDA EUA for booster dose of COVID-19 vaccine to include all individuals 18 years of age and older

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. PRY:IM
3. PRYMY
4. SPY
5. SKA-B
6. PBA
7. ALAR
8. CCH:LN
9. META
10. CCHGY

Go back to Pfizer (PFE), BioNTech (BNTX) request to amend FDA EUA for booster dose of COVID-19 vaccine to include all individuals 18 years of age and older

BioNTech (BNTX) PT Lowered to $289 at Goldman Sachs

November 11, 2021 7:19 AM EST

Goldman Sachs analyst Chris Shibutani lowered the price target on BioNTech (NASDAQ: BNTX) to $289.00 (from $433.00) while maintaining a Neutral rating.

The analyst commented, "While vaccine marketplace trends continue to provide tailwinds for mRNA-vaccine manufacturers, more hesitant management commentary around the endemic phase... More